Everything you need to know about the Wegovy tablet price in the UK
Prices in this article were checked in September 2026. They are subject to change and should be verified directly with each provider before ordering.
- What the Wegovy tablet is and how it differs from the Wegovy injection and from Rybelsus
- A comparison of current UK pricing by dose
- What a quoted price should include, from clinical assessment, prescription, delivery, and support
- Why costs rise by dose, and why you should never choose based on price alone
- NHS access: The current position and what it means in practice
- How to compare providers safely
What is the Wegovy tablet?
The Wegovy tablet contains oral semaglutide and is taken once daily. It is a different product from the Wegovy injection, which contains the same active ingredient but is given as a once-weekly subcutaneous injection. The two are not interchangeable, and they follow different dose schedules.
The Wegovy tablet is also different from Rybelsus, which is another oral semaglutide product but is licensed in the UK only for type 2 diabetes, not for weight management. Rybelsus is not an alternative to the Wegovy tablet for people seeking licensed weight management treatment.
The Wegovy tablet follows a four-step dose escalation schedule:
| Dose | Typical duration |
|---|---|
| 1.5 mg once daily | Minimum 4 weeks |
| 4 mg once daily | Minimum 4 weeks |
| 9 mg once daily | Minimum 4 weeks |
| 25 mg once daily | Maintenance dose |
Each dose is prescribed as a 30-tablet monthly supply. The tablet must be taken on an empty stomach, after at least eight hours without food, with no more than 120 ml of plain water, followed by a 30-minute wait before eating, drinking, or taking other medicines.
Current private Wegovy tablet prices in the UK
The table below shows standard private prices for a 30-tablet monthly supply at each dose across a selection of UK providers, based on published pricing checked in September 2026. Standard prices are shown separately from introductory offers, subscriptions, or promotional pricing, which may not reflect the ongoing cost of treatment.
| Provider | 1.5 mg | 4 mg | 9 mg | 25 mg | Prices checked |
|---|---|---|---|---|---|
| Oxford Online Pharmacy | £79.99 | Not published | Not published | Not published | September 2026 |
| Medino | £98.99 | £107.99 | £125.99 | £179.99 | September 2026 |
| Simple Online Pharmacy | £129 | Not published | Not published | £170 | September 2026 |
| Rightangled | £114.99 | £119.99 | £139.99 | £194.99 | September 2026 |
| Bolt Pharmacy | From £99 | Not published | Not published | From £189 | September 2026 |
| Happy Pharmacy | £99 | £119 | £149 | £199 | September 2026 |
Prices are standard published rates and exclude introductory discounts, subscription offers, or promotional pricing. Prices change; verify the current figure directly with the provider before ordering. Some providers did not publish prices at every dose at the time of checking.
As a general guide across the market, standard private prices range from approximately £70 to £130 per month at the 1.5 mg starting dose, rising to approximately £170 to £200 per month at the 25 mg maintenance dose.
What a quoted price should include
Headline prices vary partly because providers include different things in what they advertise. Before comparing on price alone, it is worth establishing what each provider's quoted figure covers.
Clinical assessment
A valid prescription requires a medical assessment by a UK-registered prescriber. Some providers include this in the headline price; others charge a separate consultation fee. A provider that does not require a clinical assessment before issuing a prescription is not operating legally or safely.
The medicine itself
The cost of the 30-tablet monthly supply at the prescribed dose. This is the core component of any quoted price, but it is worth confirming whether the figure shown is for a standard pack or a promotional first-month price, as some providers offer a reduced rate for the initial supply that does not reflect the ongoing monthly cost at that dose.
Prescription fee
Some providers separate the prescribing fee from the medicine cost; others bundle them. Confirm with your provider whether the quoted price includes the prescription or if that is a separate fee.
Delivery
Most UK online providers include standard delivery in the price, but some charge separately for faster delivery options.
Ongoing prescriber support and follow-up
Legitimate providers offer access to clinical support during treatment, not just at the initial consultation. This matters because dose management, side effects, and any concerns during treatment require ongoing prescriber availability. Check what is available and whether it is included or charged separately.
Cancellation and refund conditions
Understand what happens if you need to pause or stop treatment, if a prescription is declined following assessment, or if the medicine is out of stock after payment has been taken. Some providers offer a full refund if a prescription is declined; others do not. Subscription or multi-month pricing arrangements may have specific cancellation terms that are worth reading before committing. If a provider does not make its cancellation and refund policy clearly available, that is worth noting before ordering.
Good to know
A lower headline price that excludes consultation, prescription, or follow-up support may end up costing the same as or more than a higher headline price that bundles everything in. Total cost of treatment, rather than the starting dose price alone, is the more useful basis for comparison.
Why costs rise by dose, and why dose should not be chosen based on price
The price of the Wegovy tablet increases with dose strength. This reflects the higher cost of manufacturing higher-dose tablets and is consistent with how most prescription weight management medicines are priced.
The dose escalation schedule exists for clinical reasons. Each step up allows the body to adjust to the medicine and reduces the risk of gastrointestinal side effects. The maintenance dose of 25 mg is reached after a minimum of four months at the lower doses, and some people achieve a satisfactory response at an earlier step and remain there.
The appropriate dose at any point in treatment is a clinical decision made by a prescriber based on your response to the current dose, your tolerability, and your overall health picture. It is not a decision that should be influenced by the cost difference between dose levels. Taking a lower dose than clinically appropriate to reduce monthly costs, or pushing to a higher dose faster than advised to accelerate results, both carry clinical risks and are outside the terms of the medicine's licensed use.
Important!
Never choose or adjust your dose based on price. If you have concerns about the ongoing cost of treatment, discuss them with your prescriber, who can advise on the most appropriate approach for your circumstances.
NHS access
The MHRA authorisation granted on 11 June 2026 means the Wegovy tablet is a licensed medicine in the UK. It does not mean it is available on the NHS.
NHS medicine is a separate decision, made through a NICE technology appraisal. NICE assesses whether a medicine represents sufficient clinical and cost-effectiveness to recommend NHS funding. This process typically takes 12 to 18 months following MHRA authorisation and had not been completed for the Wegovy tablet at the time of writing.
The Wegovy injection is available on the NHS through specialist weight management services under NICE TA875. Mounjaro (tirzepatide) is available on the NHS under NICE TA1026, subject to eligibility criteria. Neither of these appraisals covers the Wegovy tablet, which is a separate product requiring its own NICE assessment.
How to compare providers safely
Price is one factor in choosing a provider for prescription weight management treatment. Regulatory compliance and clinical quality matter at least as much.
Verify GPhC registration
Any pharmacy dispensing prescription medicines in Great Britain must be registered with the General Pharmaceutical Council. Registration can be checked at gphc.org.uk. Registered online pharmacies are required to display the GPhC internet pharmacy logo; clicking it should link directly to the pharmacy's entry on the register.
Confirm a genuine clinical assessment is required
A legitimate provider will require you to complete a medical questionnaire that is reviewed by a UK-registered prescriber before any prescription is issued. If a provider offers to supply the Wegovy tablet without this step, it is not operating within the law.
Check who the prescriber is
The prescriber reviewing your assessment should be a UK-registered doctor, nurse prescriber, or pharmacist prescriber. Most legitimate providers make this information available.
Be cautious of prices significantly below the market range
Prescription medicines have a cost that reflects pharmaceutical manufacturing, quality control, cold chain requirements, and regulatory compliance. Prices that appear significantly lower than the market range are worth investigating carefully before ordering.
Avoid unregulated sources entirely
The Wegovy tablet should not be purchased from social media sellers, beauty salons, aesthetic clinics without prescribing authority, or any source that does not require a medical assessment and valid prescription. The MHRA has issued clear warnings about counterfeit and substandard weight loss medicines. A product sold without a prescription check is not a legitimate medicine supply, regardless of how it is packaged or presented.
Important!
The Wegovy tablet is a prescription-only medicine. It cannot be legally supplied without a valid prescription from a UK-registered prescriber. Any source offering it without a clinical assessment is operating illegally and poses a genuine risk to your health.
Conclusion
The Wegovy tablet is a newly authorised treatment with a growing number of UK providers offering private prescriptions. Prices vary by dose and by provider, and the starting dose price is not a reliable basis for comparing providers, as what is included in the quoted figure differs considerably.
The most important considerations when accessing any prescription weight management medicine are regulatory compliance, the quality of the clinical assessment, and the ongoing prescriber support available during treatment. Price is a legitimate factor, but it should be evaluated in the context of what is included, not as a standalone figure.
The Wegovy tablet is not currently available on the NHS. For people who may be eligible for NHS weight management treatment, speaking to a GP about existing options under NICE TA875 (Wegovy injection) or NICE TA1026 (Mounjaro) is worth exploring alongside or before pursuing a private prescription.
FAQ
How much does the Wegovy tablet cost in the UK?
Standard private prices range from approximately £70 to £130 per month at the 1.5 mg starting dose, rising to approximately £170 to £200 per month at the 25 mg maintenance dose, based on prices checked in September 2026. Prices vary by provider and change over time; verify the current figure directly with the provider before ordering.
Is the Wegovy tablet available on the NHS?
Not at present. The Wegovy tablet received MHRA authorisation in June 2026, but NHS funding requires a separate NICE technology appraisal, which had not been completed at the time of writing. NHS availability is unlikely before 2027. The Wegovy injection and Mounjaro are available on the NHS for eligible patients under existing NICE guidance.
Is the Wegovy tablet the same as Rybelsus?
No. Both contain oral semaglutide, but they are different products with different licensed indications. Rybelsus is licensed in the UK for type 2 diabetes only. The Wegovy tablet is licensed for weight management. They are not interchangeable.
Is the Wegovy tablet the same as the Wegovy injection?
They contain the same active ingredient, semaglutide, but are taken differently and follow different dose schedules. The Wegovy tablet is a once-daily oral tablet; the Wegovy injection is a once-weekly subcutaneous injection. They are separate products with separate prescriptions.
Why does the price increase with each dose?
Higher dose tablets cost more to manufacture, and pricing reflects this. The dose escalation schedule follows a clinical rationale, not a pricing one. The appropriate dose at any stage of treatment is a clinical decision and should not be influenced by cost.
How do I find a legitimate provider for the Wegovy tablet?
Verify that the provider uses a GPhC-registered pharmacy, requires a genuine clinical assessment by a UK-registered prescriber before issuing a prescription, and offers ongoing prescriber support during treatment. Check GPhC registration at gphc.org.uk.
The DoktorABC medical advisory board
Dr. Roland Ruiken
Medical advisor, Norway
Dr. Viktor Simunovic
Medical advisor, Croatia